https://www.selleckchem.com/pr....oducts/tegatrabetan.
This estimate increased to 34% after correcting for influenza vaccination exposure misclassification. We observed significant VE against deaths following influenza confirmation during 2014-2015 (VE=26% [95%CI, 5%-42%]). We also observed significant VE against deaths following confirmation of influenza A/H1N1 and A/H3N2, and against deaths with COPD as the underlying cause. These results support the importance of influenza vaccination in older adults, who account for most influenza-associated deaths annually. These results support t